Mathilde Hunault

6.9k total citations · 1 hit paper
111 papers, 2.2k citations indexed

About

Mathilde Hunault is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mathilde Hunault has authored 111 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Hematology, 36 papers in Genetics and 34 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mathilde Hunault's work include Acute Myeloid Leukemia Research (47 papers), Acute Lymphoblastic Leukemia research (33 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Mathilde Hunault is often cited by papers focused on Acute Myeloid Leukemia Research (47 papers), Acute Lymphoblastic Leukemia research (33 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Mathilde Hunault collaborates with scholars based in France, United States and Switzerland. Mathilde Hunault's co-authors include Norbert Ifrah, Kenneth A. Bauer, Patrice Chevallier, Hervé Dombret, Jean‐Luc Harousseau, Arnaldo Arbini, Josephine A. Carew, Nöel Milpied, Nicolas Boissel and Agnès Buzyn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mathilde Hunault

103 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of ALL in adults: 2024 ELN recommendations from a European expert panel

2024 45 citations Nicolas Boissel, Hervé Dombret et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathilde Hunault France	27	1.3k	653	632	519	507	111	2.2k
Matthew D. Seftel Canada	24	741 0.6×	401 0.6×	524 0.8×	289 0.6×	225 0.4×	111	1.6k
Marinus van Marwijk Kooy Netherlands	23	2.1k 1.6×	605 0.9×	658 1.0×	375 0.7×	843 1.7×	44	2.6k
Mar Tormo Spain	32	2.1k 1.6×	1.0k 1.6×	646 1.0×	506 1.0×	1.3k 2.6×	106	3.1k
Michael J. Barnett Canada	30	1.8k 1.4×	516 0.8×	698 1.1×	1.0k 2.0×	474 0.9×	115	2.9k
Piera Viero Italy	24	1.2k 0.9×	498 0.8×	675 1.1×	737 1.4×	336 0.7×	81	2.3k
Ichiro Tsukimoto Japan	26	1.6k 1.2×	605 0.9×	519 0.8×	320 0.6×	397 0.8×	78	2.2k
Donna L. Forrest Canada	27	1.4k 1.0×	292 0.4×	482 0.8×	737 1.4×	422 0.8×	110	2.3k
Masamitsu Yanada Japan	27	2.0k 1.5×	1.0k 1.5×	366 0.6×	456 0.9×	620 1.2×	121	2.5k
André Delannoy Belgium	26	1.5k 1.2×	1.4k 2.2×	581 0.9×	754 1.5×	271 0.5×	104	2.9k
Sang Kyun Sohn South Korea	28	1.4k 1.1×	310 0.5×	723 1.1×	567 1.1×	600 1.2×	191	2.7k

Countries citing papers authored by Mathilde Hunault

Since Specialization

Citations

This map shows the geographic impact of Mathilde Hunault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Hunault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Hunault more than expected).

Fields of papers citing papers by Mathilde Hunault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Hunault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Hunault. The network helps show where Mathilde Hunault may publish in the future.

Co-authorship network of co-authors of Mathilde Hunault

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Hunault. A scholar is included among the top collaborators of Mathilde Hunault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Hunault. Mathilde Hunault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duployez, Nicolas, Juliette Lambert, Maël Heiblig, et al.. (2023). Hyperleukocytosis Increases the Risk of Early Relapses Independently of Genetics in AML. Blood. 142(Supplement 1). 4322–4322.

Bouvier, Anne, Jérémie Riou, Sylvain Thépot, et al.. (2023). Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores. American Journal of Hematology. 98(6). 922–931. 3 indexed citations

Cabannes‐Hamy, Aurélie, Éolia Brissot, Thibaut Leguay, et al.. (2022). High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL. Haematologica. 107(9). 2072–2080. 24 indexed citations

Riou, Jérémie, Pierre Péterlin, Tony Marchand, et al.. (2022). Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia—a Grand Ouest Against Leukemia (GOAL) study. Leukemia. 36(10). 2408–2417. 4 indexed citations

Duployez, Nicolas, Martin Figeac, Sandrine Geffroy, et al.. (2022). Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r. BMC Bioinformatics. 23(1). 448–448.

Devillier, Raynier, Édouard Forcade, Alice Garnier, et al.. (2021). In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study. Blood Advances. 6(6). 1804–1812. 17 indexed citations

Groh, Matthieu, Laura Venditti, Émilie Chalayer, et al.. (2021). FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction. Stroke. 52(10). e605–e609. 5 indexed citations

Lacombe, Valentin, Sylvain Thépot, Sylvie François, et al.. (2021). Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations. European Journal Of Haematology. 107(4). 489–496. 1 indexed citations

Touzart, Aurore, Étienne Lengliné, Mohamed Belhocine, et al.. (2019). Epigenetic Silencing Affects l -Asparaginase Sensitivity and Predicts Outcome in T-ALL. Clinical Cancer Research. 25(8). 2483–2493. 28 indexed citations

10.

Bouvier, Anne, Jérémie Riou, Sylvain Thépot, et al.. (2019). Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation. Leukemia. 34(5). 1342–1353. 5 indexed citations

11.

Orvain, Corentin, Damien Luque Paz, Irène Dobo, et al.. (2016). Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study. Annals of Hematology. 95(11). 1819–1823. 6 indexed citations

12.

Thépot, Sylvain, Simone Boehrer, Thomas Prébet, et al.. (2014). A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure. Leukemia Research. 38(12). 1430–1434. 13 indexed citations

13.

Pigneux, Arnaud, Jean‐Luc Harousseau, Francis Witz, et al.. (2010). Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS. Journal of Clinical Oncology. 28(18). 3028–3034. 26 indexed citations

14.

Schmidt, Aline, M. Avenel‐Audran, Anne Croué, et al.. (2009). Dermatose neutrophilique aiguë induite par le bortezomib. Annales de Dermatologie et de Vénéréologie. 136(5). 443–446. 9 indexed citations

15.

Chevallier, Patrice, Mathilde Hunault, Fabrice Larosa, et al.. (2008). A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial. Leukemia Research. 33(8). 1124–1126. 12 indexed citations

16.

Hunault, Mathilde, Jean‐Luc Harousseau, Serge Bologna, et al.. (2007). Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial. Haematologica. 92(12). 1623–1630. 25 indexed citations

17.

Hunault, Mathilde, Aline Schmidt, Vincent Lévy, et al.. (2005). rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study. Bone Marrow Transplantation. 35(9). 903–907. 4 indexed citations

18.

Hunault, Mathilde, Nöel Milpied, Marc Bernard, et al.. (2001). Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. Leukemia. 15(6). 898–902. 17 indexed citations

19.

Dobo, Irène, Danielle Pineau, Marc Zandecki, Mathilde Hunault, & Sylvie Hermouet. (1999). Endogenous Erythroid and Megakaryocytic Colony Formation in Serum-Free, Cytokine-Free Collagen Gels. Journal of Hematotherapy & Stem Cell Research. 8(6). 601–607. 13 indexed citations

20.

Hunault, Mathilde, Marie‐Claude Guillin, & Kenneth A. Bauer. (1999). Les déficits constitutionnels en facteur VII de la coagulation et les mécanismes moléculaires qui en sont responsables. Hématologie. 5(3). 199–205. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact